biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by GlassHalfEmptyon Aug 26, 2013 9:18am

284 Views

Post# 21697147

RE:RE:RE:Waiting for some news

First, Rob is an eternal optimist.
Second, what else would you expect him to say?
Things are not going good
I don't think so.
I don't usually waste my time writing to management
(you know the saying "ask no questions get told no lies)
But I did write Rob about a year ago
And was surprised not only to get a very fast response
But on a Sunday even.
Much the same as your reply.
Different topic but same be happy
All is good

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading